ERBB2 and breast carcinoma: In this study, we found that warangalone significantly inhibited cell viability of 3 breast cancer cell lines: MDA-MB-231 (TNBC), ZR75-1 (Luminal B), and SKBR3 (HER2+), but had no obvious toxicity to normal breast cells.